A Double-Blind, Placebo-Controlled, Single-Dose Escalation and Food Effect Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ONO-2952 in Healthy Adult Subjects.

Trial Profile

A Double-Blind, Placebo-Controlled, Single-Dose Escalation and Food Effect Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ONO-2952 in Healthy Adult Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 03 Aug 2015

At a glance

  • Drugs ONO 2952 (Primary)
  • Indications Irritable bowel syndrome
  • Focus Adverse reactions
  • Acronyms SAD
  • Most Recent Events

    • 03 Aug 2015 Results of MAD and SAD study published in the Clinical Therapeutics.
    • 17 Jan 2012 Actual end date (Aug 2011) added as reported by ClinicalTrials.gov.
    • 17 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top